← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Sixal Corporation
Santa Monica, CA
$2,176,201
Total funding
3
Grants
Funding over time
peak $749.9K · FY2012–20$1M$750K$500K$250K$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$2,176,201 · 3
By mechanism
R44$1,489,545 · 1
R43$686,656 · 2
Investigators at Sixal Corporation
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Targeting surface-bound IgE as a novel allergy therapeutic$749,892
R44 · FY2015 · AI
Targeting surface-bound IgE as a novel allergy therapeutic$739,653
R44 · FY2016 · AI
Safety and efficacy of an allergy therapeutic targeting FcERI bound IgE in human immune reconstituted mice.$286,656
R43 · FY2020 · AI
Targeting surface-bound IgE as a novel allergy therapeutic$200,000
R43 · FY2012 · AI
Targeting surface-bound IgE as a novel allergy therapeutic$200,000
R43 · FY2013 · AI